Insilico Medicine ("Insilico"), a clinical-stage, generative AI-driven drug discovery company, today announced the ...

BridgeBio Pharma (NASDAQ:BBIO) hosted an investor webinar to outline its clinical and commercial strategy for infigratinib, ...

Phase 1 results confirm investigational drug-candidate G1090N has a favorable safety and tolerability profile, supporting further clinical evaluationCompelling anti-inflammatory activity of G1090N was ...

Cumulus Neuroscience, a leading innovator in brain health technology for clinical trials, today announced the publication of ...

The Central Bank of the UAE has announced plans to introduce the initial phase of the digital dirham, signalling a significant development in the country’s financial landscape. According to the ...

CT-155 (Boehringer Ingelheim and Click Therapeutics), an investigational prescription digital therapeutic, was both safe and effective in reducing negative symptoms of schizophrenia in a new phase 3 ...

The lithium niobate thin-film modulator was designed to achieve a modulation frequency of 350 kHz within the 0–2π phase range, further realizing high-speed control of optical field coherence. Credit: ...

A hybrid phase demodulation structure combining a 3 × 3 coupler and Sagnac interferometer is proposed to improve the spatial resolution and phase demodulation performance of the phase-sensitive ...